You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hepatic glucose production

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Type 1 Diabetes Trial (HDV-Insulin Lispro)

Not yet recruiting
  • Type 1 Diabetes
  • HDV-Insulin Lispro
  • (no location specified)
Jan 9, 2023

Diabetes, Type 2 Trial in San Antonio (Dapagliflozin, Placebo)

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • San Antonio, Texas
    University of Texas Health Science Center
Aug 5, 2022

Non-Alcoholic Fatty Liver Disease, Non-alcoholic Steatohepatitis, Glucose Metabolism Disorders Trial in Aarhus (glucagon)

Completed
  • Non-Alcoholic Fatty Liver Disease
  • +2 more
  • glucagon
  • Aarhus, Danmark, Denmark
    Aarhus University Hospital
Nov 3, 2022

Type II; Diabetes Trial in San Antonio (Dapagliflozin, Placebo)

Completed
Has Results
  • Type II; Diabetes
  • San Antonio, Texas
    University of Texas Health Science Center
Dec 2, 2019

Insulin-stimulated Hepatic Glucose Uptake by PET-CT Measurements

Recruiting
  • NAFLD
  • +2 more
    • Maastricht, Netherlands
      Maastricht University
    Apr 12, 2022

    Liver Cancer Trial in Glen Burnie (CO Testing Pre/Post Hepatic Resection, ABG Testing Pre/Post Hepatic Resection, CT

    Recruiting
    • Liver Cancer
    • CO Testing Pre/Post Hepatic Resection
    • +2 more
    • Glen Burnie, Maryland
      University of Maryland Baltimore Washington Medical Center
    May 13, 2022

    Type 2 Diabetes, Glucose Metabolism Disorders, Glucose, High Blood Trial in Bronx (Diazoxide, Nicotinic acid, Placebo)

    Recruiting
    • Type 2 Diabetes Mellitus
    • +2 more
    • Bronx, New York
      Albert Einstein College of Medicine
    Jun 15, 2022

    Type 2 Diabetes Trial in San Antonio (Canagliflozin, Liraglutide)

    Completed
    Has Results
    • Type 2 Diabetes Mellitus
    • San Antonio, Texas
      University of Texas Health Science Center at San Antonio
    Dec 10, 2019

    Glycogen Storage Disease Type IA Trial in Groningen ([6,6-2H2]glucose)

    Completed
    • Glycogen Storage Disease Type IA
    • [6,6-2H2]glucose
    • Groningen, Netherlands
      University of Groningen, UMC Groningen
    Feb 10, 2022

    Pre-diabetes Trial in Québec (Low fat diet, High fat diet)

    Recruiting
    • Pre-diabetes
    • Low fat diet
    • High fat diet
    • Québec, Quebec, Canada
      Institute of Nutrition and Functional Foods (INAF)
    Jul 20, 2023

    Fatty Liver Disease Trial in Tainan (Canagliflozin 100mg)

    Completed
    • Fatty Liver Disease
    • Canagliflozin 100mg
    • Tainan, Taiwan
      National Cheng Kung University Hospital
    Feb 28, 2023

    Pre-diabetes Trial (Intervention)

    Not yet recruiting
    • Pre-diabetes
    • Intervention
    • (no location specified)
    Jun 22, 2023

    Nutrition, Healthy, Dietary Deficiency, Bone Resorption Trial in Palermo (Control Group, Biostimulated group)

    Completed
    • Nutrition, Healthy
    • +5 more
    • Control Group
    • Biostimulated group
    • Palermo, Italy
      NABbio, STEBICEF department
    Jul 30, 2023

    Polycystic Ovarian Syndrome, Obesity, Hepatic Steatosis Trial in Aurora (Essential Amino Acid (EAA) Supplement, Placebo)

    Completed
    • Polycystic Ovarian Syndrome
    • +2 more
    • Essential Amino Acid (EAA) Supplement
    • Placebo
    • Aurora, Colorado
      University of Colorado, Anschutz Medical Campus
    Mar 4, 2022

    Type 2 Diabetes, Type 1 Diabetes Trial in San Antonio (Empagliflozin 25 MG, Placebo)

    Not yet recruiting
    • Type 2 Diabetes
    • Type 1 Diabetes
    • Empagliflozin 25 MG
    • Placebo
    • San Antonio, Texas
      Texas Diabetes Institute/UH
    Jul 31, 2023

    Insulin Resistance Trial in Nashville (Trimethaphan, Saline)

    Withdrawn
    • Insulin Resistance
    • Nashville, Tennessee
      Vanderbilt University Medical Center
    Jun 3, 2021

    Adolescent Obesity Trial in New York (Fructose + Glucose Beverage)

    Recruiting
    • Adolescent Obesity
    • Fructose + Glucose Beverage
    • New York, New York
      Weill Cornell Medicial College
    Sep 16, 2022

    Role of the Liver in Glucose Homeostasis Using Metabolic Imaging

    Completed
    • Type 1 Diabetes
    • Bariatric Surgery Candidate
    • Multiparametric, multinuclear MR (DMI/ 13C-MRS/ GlycoCEST/GlycoNOE)
    • Bern, Switzerland
      Inselspital, Bern University Hospital and University Hospital of
    Nov 14, 2022

    End Stage Renal Disease Trial in Pisa (Empagliflozin, Placebo)

    Completed
    • End Stage Renal Disease
    • Empagliflozin
    • Placebo
    • Pisa, Italy
      Department of Endocrinology and Metabolism, University of Pisa
    Sep 13, 2021

    Hypoglycemia, type1diabetes Trial in Cincinnati (Fasting, Feeding)

    Recruiting
    • Hypoglycemia
    • type1diabetes
    • Fasting
    • Feeding
    • Cincinnati, Ohio
      University of Cincinnati
    Aug 2, 2023

    Diabetes, Type 2 Trial in San Antonio (Placebo, Exenatide, Dapagliflozin)

    Active, not recruiting
    • Diabetes Mellitus, Type 2
    • Placebo
    • +3 more
    • San Antonio, Texas
      University Health System Texas Diabetic Institute
    Apr 28, 2022

    Type 2 Diabetes Trial in Charlottesville (Metformin, Insulin Glargine, Dorzagliatin)

    Recruiting
    • Type 2 Diabetes
    • Charlottesville, Virginia
      Rita Basu
    Jul 19, 2022

    Pancreatic Imaging Correlates in Cystic Fibrosis

    Completed
    • Cystic Fibrosis
    • +4 more
    • Frequently Sampled Oral Glucose Tolerance Test and CGM
    • MRI Pancreas and Liver
    • Cleveland, Ohio
      University Hospitals Cleveland Medical Center
    May 16, 2022

    Type 2 Diabetes Trial (Pramlintide acetate, Placebo)

    Withdrawn
    • Type 2 Diabetes
    • Pramlintide acetate
    • Placebo
    • (no location specified)
    Jul 18, 2021

    Renal Failure Trial in Pierre-Bénite (keto-analogs)

    Recruiting
    • Renal Failure
    • Pierre-Bénite, France
      Centre Hospitalier Lyon SUD
    Jul 5, 2021